(19)
(11) EP 4 329 729 A1

(12)

(43) Date of publication:
06.03.2024 Bulletin 2024/10

(21) Application number: 22796265.1

(22) Date of filing: 27.04.2022
(51) International Patent Classification (IPC): 
A61K 9/08(2006.01)
A61K 47/10(2017.01)
A61K 47/22(2006.01)
A61P 31/00(2006.01)
A61K 39/395(2006.01)
A61K 47/18(2017.01)
A61K 47/26(2006.01)
A61P 35/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 31/00; A61K 47/10; A61K 47/26; A61P 35/00; A61K 47/18; A61K 9/08; C07K 16/2818; A61K 39/39591; C07K 2317/76; C07K 2317/24; A61K 9/19; A61K 47/22; A61K 9/0019
(86) International application number:
PCT/RU2022/050140
(87) International publication number:
WO 2022/231481 (03.11.2022 Gazette 2022/44)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 27.04.2021 RU 2021112111

(71) Applicant: Joint Stock Company "Biocad"
St. Petersburg 198515 (RU)

(72) Inventors:
  • KOSTANDIAN, Alina Aleksandrovna
    Saint Petersburg 193313 (RU)
  • ANDREEVA, Anastasiia Alekseevna
    Saratov 410056 (RU)
  • LOMKOVA, Ekaterina Aleksandrovna
    Saint Petersburg 196066 (RU)
  • IAKOVLEV, Aleksandr Olegovich
    Moscow 109651 (RU)
  • MOROZOV, Dmitry Valentinovich
    Saint Petersburg 190000 (RU)

(74) Representative: Meissner Bolte Partnerschaft mbB 
Widenmayerstrasse 47
80538 München
80538 München (DE)

   


(54) PHARMACEUTICAL COMPOSITION OF PEMBROLIZUMAB AND USE THEREOF